Clinical trial

Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach

NCT00002682 · M.D. Anderson Cancer Center, Other · Completed

Key facts

NCT number NCT00002682
Title Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
Official title CURRENT PRACTICE STUDY OF ANTIBIOTIC TREATMENT OF GASTRIC MALT LYMPHOMA
Lead sponsor M.D. Anderson Cancer Center, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Lymphoma
Intervention type Drug
Interventions Amoxicillin, Bismuth Subsalicylate, Clarithromycin, Metronidazole Hydrochloride, Omeprazole, Tetracycline Hydrochloride
Enrollment 5
Start date Aug 10, 1995
Primary completion Oct 8, 2001
Completion Oct 8, 2001
First posted Jun 10, 2004
Last update posted Oct 24, 2018
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies